Back to search
FDAFDA · Food and drugs·Recall number D-0042-2023

PAPAVERINE / PHENTOLAMINE / PROSTAGLANDIN 150MG / 2.5MG / 50MCG SOLUTION, 5 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

Published November 9, 2022 · Recall initiated: October 7, 2022

Summary

FDA records drug Class II recall D-0042-2023, published November 9, 2022 and initiated October 7, 2022. Recalling firm: Pharmacy Plus, Inc. dba Vital Care Compounder; Status: Ongoing; Reported quantity: 56 vials; Lot: Lots: 64409, BUD: 04/08/2023; 60849, BUD: 05/23/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pharmacy Plus, Inc. dba Vital Care Compounder
Distributor
AL, LA, MS, and TN
Lot
Lots: 64409, BUD: 04/08/2023; 60849, BUD: 05/23/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PAPAVERINE / PHENTOLAMINE / PROSTAGLANDIN 150MG / 2.5MG / 50MCG SOLUTION, 5 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402 recalled?

Yes. FDA published recall D-0042-2023 on November 9, 2022. Reported hazard: Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone